---
title: WFSBP Guidelines for Treatment of Unipolar Depressive Disorders
organization: World Federation of Societies of Biological Psychiatry (WFSBP)
year: 2023
category: depression
---

# WFSBP Guidelines for Biological Treatment of Unipolar Depressive Disorders

## First-Line Treatments for Acute Phase

### Recommended First-Line Antidepressants (Evidence Grade A):
- **SSRIs**: Escitalopram, sertraline, citalopram, paroxetine, fluoxetine
- **SNRIs**: Venlafaxine, duloxetine, desvenlafaxine
- **Other**: Bupropion, mirtazapine, agomelatine, vortioxetine

### Treatment Principles:
1. **Adequate dose**: Start with therapeutic dose and titrate as needed
2. **Adequate duration**: 4-6 weeks minimum for initial response; 6-8 weeks for full assessment
3. **Monitor response**: Use rating scales (PHQ-9, MADRS, HAM-D)

## Moderate to Severe Depression

### Monotherapy Options:
- SSRIs/SNRIs as first-line
- Mirtazapine or bupropion as alternatives
- Tricyclics (TCAs) effective but poorer tolerability

### Augmentation Strategies (for partial response):
1. **Evidence Grade A**:
   - Add second-generation antipsychotic (aripiprazole, quetiapine XR, brexpiprazole)
   - Add lithium (especially if family history of bipolar disorder)
   - Combination antidepressants (e.g., SSRI + bupropion or mirtazapine)

2. **Evidence Grade B**:
   - Add thyroid hormone (T3 or T4)
   - Add buspirone
   - Add lamotrigine

## Treatment-Resistant Depression (TRD)

### Definition:
Inadequate response to ≥2 adequate trials of antidepressants from different classes

### Strategies:
1. **Switch within class or to different class**
2. **Augmentation** (see above)
3. **Electroconvulsive Therapy (ECT)**: Most effective acute treatment for TRD
4. **Transcranial Magnetic Stimulation (rTMS)**: Evidence Grade A
5. **Ketamine/Esketamine**: Rapid-acting; Evidence Grade B-C
6. **MAOIs**: Effective but require dietary restrictions; use as later-line

## Continuation and Maintenance Phase

### Duration:
- **First episode**: 6-12 months after remission
- **Recurrent depression (≥2 episodes)**: 2-3 years minimum
- **Highly recurrent (≥3 episodes) or chronic**: Consider indefinite maintenance

### Dosing:
- Continue same dose that achieved remission

## Special Populations

### Elderly:
- Start low, go slow
- Monitor for falls, hyponatremia, drug interactions
- SSRIs and SNRIs preferred

### Pregnancy/Lactation:
- Weigh risks/benefits
- SSRIs generally considered (except paroxetine)
- Avoid TCAs in first trimester

## Psychotic Depression

### First-Line:
- Antidepressant + antipsychotic combination (Evidence Grade A)
- ECT (Evidence Grade A)

### Recommended Combinations:
- SSRI/SNRI + quetiapine, olanzapine, or aripiprazole

## Sources
- Bauer M, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: Update 2023 on acute treatment. World J Biol Psychiatry. 2023.
- WFSBP Official Guidelines 2023
